Treatment of Multiple Organ Dysfunction Syndrome by Xuebijing Injection: a Clinical Research
DOI:10.7661/CJIM.2013.2.205
中文摘要:
目的 观察血必净注射液对多器官功能障碍综合征(MODS)患者的治疗作用及机制研究。方法 选择76例2009年2月—2011年9月浙江省衢化医院ICU MODS患者,随机分为对照组(36例)和治疗组(40例),两组均予常规治疗;治疗组加用生理盐水100 mL加入血必净注射液100 mL,静脉滴注,每天2次,连续治疗7天。观察两组治疗前及治疗后3、7天APACHEⅡ评分、SOFA评分、血清降钙素原(PCT)、肿瘤坏死因子-α(TNF-α)、IL-6和IL-10,比较两组ICU停留时间及28天病死率。结果 治疗7天后,治疗组APACHE Ⅱ评分、SOFA评分、TNF-α、IL-6、IL-10及PCT均较治疗前明显下降,与对照组同期比较,差异有统计学意义(P<0.05);治疗组28天病死率和ICU住院时间、APACHE Ⅱ评分、SOFA评分与对照组比较明显下降,差异有统计学意义(P<0.05)。结论 血必净注射液可减少MODS患者ICU住院时间,其机制与调控炎症反应有关。
英文摘要:
Objective To observe the effects and mechanisms of Xuebijing Injection (XI) on multiple organ dysfunction syndrome (MODS) patients. Methods Recruited were 76 MODS patients at ICU, Zhejiang Provincial Quhua Hospital from February 2009 to September 2011. They were randomly assigned to the control group (36 cases) and the treatment group (40 cases). All patients received conventional treatment. Those in the treatment group were intravenously injected with XI (prepared by adding 100 mL QI in 100 mL normal saline), twice daily for seven successive days. The APACHE Ⅱ score, SOFA score, serum procalcitonin (PCT), tumor necrosis factor-α (TNF-α), interleukin 6 (IL-6) and 10 (IL-10) of the two groups were observed in the two groups before treatment, at 3 days and 7days after treatment. The ICU stay time and the 28-day mortality were compared between the two groups. Results After seven days of treatment, the APACHE Ⅱ score, SOFA score, TNF-α, IL-6, IL-10, and PCT significantly decreased in the treatment group, showing statistical difference when compared with the control group at the same time point (P<0.05). The 28-day mortality, the ICU stay time, APACHE Ⅱ score, and SOFA score decreased more significantly in the treatment group than in the control group, showing sstatistical difference (P<0.05). Conclusion XI could significantly reduce the ICU stay time of MODS patients, and its mechanisms might be correlated to regulating inflammatory reactions.
[1] 杨斌,高建军,林江.血必净注射液对急危重症患者多器官功能障碍的阻断作用研究[J].临床军医杂志,2012,40(4):830-833.
[2] 杨斌,高建军,林江.血必净注射液对急危重症患者多器官功能障碍的阻断作用研究[J].解放军医学高等专科学校学报,2012(4):830-833.
[3] 王健,周晓燕,孙滢,刘云月.乌司他丁联合血必净注射液治疗外伤后多器官功能障碍综合征临床观察[J].中国中医急症,2013,22(3).
[4] 方凯,王晓玲,顾霞,杨秋林,彭伟,陈华文.大黄对危重病患者多器官功能障碍综合征的保护作用及机制研究[J].中国现代应用药学,2012,29(10):953-956.
[5] 姜小敢,鲁卫华,金孝岠,吴敬医,沈光贵,王箴.血必净注射液治疗急性呼吸窘迫综合征临床研究[J].中国临床药理学与治疗学,2012,17(2):220-224.
[6] 刘树峰,虎晓岷.血必净对危重病患者可溶性髓系细胞表达触发受体1及炎症因子表达的影响[J].临床荟萃,2012,27(20):1762-1764.
[7] 康福新,贾利平,王小智.血必净注射液对凝血功能障碍危重病患者的临床价值研究[J].中国急救医学,2010,30(4).
[8] 黄伟,杜梁枫,潘兆麟,苗宗宁.血必净注射液对MODS患者凝血功能的影响[J].北京中医,2009(7).
[9] 黄伟,杜梁枫,潘兆麟,苗宗宁.血必净注射液对MODS患者凝血功能的影响[J].北京中医药,2009,28(7):543-544.
[10] 王静恩,蔡金芳,王志华,谢晓洪,瞿炜,朱念,高波,盛鹰,顾佳士.血必净注射液对多发性创伤患者早期的治疗作用及对预后的影响[J].中国中西医结合急救杂志,2008,15(5).
[11] 张晓娟,章志丹,穆恩,梁英健,栾正刚,郑振,肇冬梅,李旭,马晓春.脓毒症患者早期应用血必净注射液治疗的临床研究[J].中国中西医结合急救杂志,2010,17(3):172-174.
[12] 刘明文,刘云龙.血必净注射液治疗全身炎症反应综合征患者的临床分析[J].临床内科杂志,2011,28(5).
[13] 王蔼卿,曹书华,常文秀.血必净对多器官功能障碍综合征患者血浆蛋白C活性的影响[J].天津医科大学学报,2007,13(2):235-237.
[14] 唐皓,詹红,关开泮,李欣,荆小莉,廖晓星,马中富,梁艳冰,熊艳.血必净注射液对MODS患者高级氧化蛋白产物和C反应蛋白表达的影响[J].南方医科大学学报,2009,29(9).
[15] 何淑寅.血必净注射液对多器官功能不全患者凝血功能的影响[J].中国中医急症,2011,20(12).
[16] 陈达,贾浩,朱杰,王斯闻,王绍久,李岭.血必净治疗脓毒症临床疗效观察[J].医学临床研究,2011,28(12):2300-2302.
[17] 陈大勇,黎焯基,陈华新,谢华文,蔡必林.血必净对恙虫病患者多器官功能障碍的保护作用及机制[J].广东寄生虫学会年报,2011(10):1151-1152,1189.
[18] 刘雪峰,李文放,赵良,林兆奋.血必净注射液对重症监护病房严重脓毒症患者器官功能保护作用的临床研究[J].中国中西医结合急救杂志,2010,17(1).
[19] 陈齐红,郑瑞强,林华,汪华玲,卢年芳,邵俊,於江泉.血必净注射液对急性呼吸窘迫综合征患者预后影响的前瞻性随机对照临床研究[J].中国危重病急救医学,2009,21(7).